title: Expression of glucocorticoid receptor and early growth response gene 1 during postnatal development of two inbred strains of mice exposed to early life stress.
abstract: Early life stress can elicit profound changes in adult gene expression and behavior. One consequence of early life stress is a decreased expression of glucocorticoid receptors (GRs) in the frontal cortex and hippocampus. However, neither the time of onset nor the mechanism(s) leading to decreased GR expression during postnatal development are known. The present study used two inbred strains of mice that differ in their behavioral responsiveness to stress (Balb/c and C57Bl/6), exposed them to an established paradigm of early life stress (infant maternal separation), and measured their expression of frontal cortical and hippocampal GRs and the putative transcriptional activator of the GR gene, early growth response gene (egr)-1, at defined stages of postnatal development. In both strains, real-time RT-PCR experiments revealed that decreased expression of GR in adolescence and adulthood is, in fact, preceded by increased GR expression during early life stress exposure. Thus, the early life stress-induced disruption of the normal stress-hyporesponsive period during infancy is accompanied by increased GR expression. Moreover, chronic treatment with the antidepressant drug fluoxetine during adolescence or adulthood reversed the effect of early life stress on adult GR mRNA expression. In contrast to the strain-independent effect of early life stress on GR expression, however, changes in egr-1 expression occurred only in Balb/c mice, and unlike the biphasic developmental changes in GR mRNA expression, egr-1 mRNA was decreased throughout postnatal development. Moreover, there was no consistent overlap of anatomic regions affected by decreased GR and egr-1 protein expression. Thus, in Balb/c mice, changes in GR and egr-1 expression can independently contribute to the phenotypes resulting from early life stress exposure. These findings illustrate that the impact of early life stress on gene expression changes is modulated by the genetic background and that the persistent changes in GR and egr-1 expression that arise early during postnatal developmental are reversible by chronic fluoxetine treatment during adolescence and adulthood.
authors.affiliation: Department of Molecular Therapeutics, New York State Psychiatric Institute, New York, N.Y., USA.
authors.forename: Sylvia
authors.initials: S
authors.lastname: Navailles
authors.forename: Ross
authors.initials: R
authors.lastname: Zimnisky
authors.forename: Claudia
authors.initials: C
authors.lastname: Schmauss
mesh_terms: D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology / Q000627:therapeutic use; D051766:Early Growth Response Protein 1 / Q000235:genetics* / Q000378:metabolism; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology / Q000627:therapeutic use; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D006624:Hippocampus / Q000254:growth & development / Q000378:metabolism*; D008297:Male; D008426:Maternal Deprivation; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D019579:Neocortex / Q000254:growth & development / Q000378:metabolism*; D010641:Phenotype; D011965:Receptors, Glucocorticoid / Q000235:genetics* / Q000378:metabolism; D013315:Stress, Psychological / Q000188:drug therapy / Q000235:genetics*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D051766:Early Growth Response Protein 1; C486109:Egr1 protein, mouse; D011965:Receptors, Glucocorticoid; D005473:Fluoxetine
references.citation: Mol Endocrinol. 2000 Apr;14(4):506-17
references.pmid: 10770488
references.citation: Neurosci Biobehav Rev. 2007;31(1):3-17
references.pmid: 16950513
references.citation: Endocr Rev. 1998 Jun;19(3):269-301
references.pmid: 9626555
references.citation: Am J Psychiatry. 1993 Nov;150(11):1618-29
references.pmid: 8214170
references.citation: J Neurosci. 2007 Feb 7;27(6):1467-73
references.pmid: 17287521
references.citation: Neurosci Biobehav Rev. 2005;29(8):1335-46
references.pmid: 16095695
references.citation: Ann N Y Acad Sci. 1994 Nov 30;746:275-88; discussion 289-93
references.pmid: 7825883
references.citation: Nat Neurosci. 2005 May;8(5):664-72
references.pmid: 15834420
references.citation: Neuroendocrinology. 1995 Oct;62(4):340-7
references.pmid: 8544947
references.citation: Neuroscience. 2003;119(3):887-97
references.pmid: 12809708
references.citation: Endocrinology. 2009 Jun;150(6):2709-16
references.pmid: 19213843
references.citation: Neuroscience. 2008 Mar 18;152(2):417-28
references.pmid: 18280047
references.citation: Mol Endocrinol. 1990 Oct;4(10):1427-37
references.pmid: 1704480
references.citation: Biol Psychiatry. 2004 Feb 15;55(4):367-75
references.pmid: 14960289
references.citation: J Comp Neurol. 2008 Aug 1;509(4):372-81
references.pmid: 18512685
references.citation: J Neurosci. 2007 Feb 14;27(7):1756-68
references.pmid: 17301183
references.citation: Neuropsychopharmacology. 2004 Jul;29(7):1321-30
references.pmid: 15085085
references.citation: Brain Res Mol Brain Res. 1993 May;18(3):195-200
references.pmid: 8497182
references.citation: Brain Cogn. 2010 Feb;72(1):73-85
references.pmid: 19616355
references.citation: Trends Neurosci. 1999 Apr;22(4):167-73
references.pmid: 10203854